ijhsrp

International Journal of Health Services Research and Policy

2602-3482

Rojan GÜMÜŞ

10.23884/ijhsrp.2018.3.3.03

Health Care Administration

Sağlık Kurumları Yönetimi

Evaluation of Diastolic Dysfunction in Rheumatoid Arthritis Patients

https://orcid.org/0000-0002-6731-4958

Turgay Yıldırım

Özge

Eskişehir Devlet Hastanesi, Kardiyoloji Kliniği Gönüllü

Emel

Eskişehir Devlet Hastanesi, Romatoloji Kliniği

https://orcid.org/0000-0002-1017-1917

Aydın

Fatih

Eskişehir Devlet Hastanesi, Kardiyoloji Kliniği

https://orcid.org/0000-0002-4478-4324

Akşit

Ercan

Çanakkale Onsekiz Mart Üniversitesi, Kardiyoloji Anabilim Dalı

https://orcid.org/0000-0002-3056-9981

Hüseyinoğlu Aydın

Ayşe

Eskişehir Devlet Hastanesi, Kardiyoloji Kliniği

https://orcid.org/0000-0003-4650-969X

Dağtekin

Evrin

Eskişehir Devlet Hastanesi, Kardiyoloji Kliniği

12 26 2018

3 3 117 122 11 10 2018 12 12 2018

2016

International Journal of Health Services Research and Policy

Rheumatoid arthritis (RA) is a chronic,autoimmune inflammatory disorder which can also affect cardiovascular system.Cardiovascular system involvement can be seen in many forms such aspericarditis, myocarditis, coronary artery disease or heart failure. Diastolicdysfunction is especially important for preserved ejection fraction heartfailure patients. With this study we aim to investigate echocardiographic diastolicdysfunction parameters in RA patients.77 RA patients and 76 control subjects withoutcoronary artery disease, heart failure, valvular heart diseases were includedfor the study and echocardiography was performed. Interventricular septum(p=0.041), posterior wall diameter (p=0.008), left ventricular mass index(p=0.037) values were significantly higher and E wave (p=0.000), E/A (p=0.000),e’ (p=0.018) values were significantly lower in RA patients compared to controlgroup. In conclusion echocardiographic diastolic dysfunction parameters weredeclined in RA patients.

Rheumatoid arthritis Diastolic dysfunction Echocardiography

[1]Turesson, C., et al., “Extra‑articular disease manifestations in rheumatoid arthritis: Incidence trends and risk factors over 46 years”, Ann Rheum Dis, 62, 722‑727, 2003.

[2]Wolfe, F., et al., “The mortality of rheumatoid arthritis”, Arthritis Rheum, 37, 481-494, 1994.

[3]Solomon, D.H., et al., “Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis”, Circulation, 107, 1303-1307, 2003.

[4]Kaplan, M.J., “Cardiovascular disease in rheumatoid arthritis”, Curr Opin Rheumatol, 18, 289-297, 2006.

[5]Nicola, P.J., et al., “The risk of congestive heart failure in rheumatoid arthritis: a population based study over 46 years”, Arthritis & Rheumatology, 52, 412-420, 2005.

[6] Nicola, P.J., et al., “Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis”, Arthritis & Rheumatism, 54, 60-67, 2006.

[7] Avina-Zubieta, J.A., “Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies”, Arthritis Rheum, 59, 1690-1697, 2008.

[8]Liao, K.P., Solomon, D.H., “Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis”, Rheumatology, 52, 45-52, 2013.

[9]Daviz, J.M., et al., “A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis”, Arthritis Rheum, 63, 1497-1506, 2011.

[10]Tsang, T.S., “Left atrial volume as a morpho-physiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden”, Am J Cardiol, 90, 1284-1289, 2002.

[11]Little, W.C., Cheng, C.P., “Diastolic dysfunction”, Cardiol Rev, 6, 231-239, 1998.

[12]Devereux, R.B., et al., “Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings”, Am J Cardiol, 57, 450-458, 1986.

[13]Yazmalar, L., et al., “Seasonal disease activity and serum vitamin D levels in rheumatoid arthritis, ankylosing spondylitis and osteoarthritis”, Afr Health Sc, 13, 47-55, 2013.

[14]Pincus, T., et al. “Taking mortality in rheumatoid arthritis seriously - predictive markers, socioeconomic status and comorbidity”, J Rheumatol, 13, 841-845, 1986.

[15]Mutru, O., et al., “Cardiovascular mortality in patients with rheumatoid arthritis”, Cardiology, 76, 71-77, 1989.

[16]Lebowits, W.B., “The heart in rheumatoid arthritis (rheumatoid disease). A clinical and pathological study of 62 cases”, Ann Intern Med, 58, 102-123, 1963.

[17]Redfield, M.M., et al., “Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic”, JAMA, 289, 194-202, 2003.

[18]Bursi, F., et al., “Systolic and diastolic heart failure in the community”, JAMA, 296, 2209-2216, 2006.

[19]Di Franco, M., et al., “Diastolic function abnormalities in rheumatoid arthritis. Evaluation By echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease”, Ann Rheum Dis, 59, 227-229, 2000.

[20]Erdem, F., et al. “Epicardial fat thickness in patients with rheumatoid arthritis”, Afr Health Sci, 15, 489-495, 2015.

[21]Udayakumar, N., et al., “Diastolic function abnormalities in rheumatoid arthritis: relation with duration of disease”, Singapore Med J, 48, 537-542, 2007.

[22]Rudominer, R.L., et al., “Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction”, Arthritis Rheum, 60, 22-29, 2009.

[23]Myasoedova, E., et al., “Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a populationbased cross-sectional study”, Arthritis Rheum, 65, 1713-1718, 2013.

[24] Midtbø, H., et al., “Disease activity and left ventricular structure in patients with rheumatoid arthritis”, Rheumatology (Oxford), 54, 511-519, 2015.